Convalo Health International Corp. reported earnings results for the fourth quarter and full year ended November 30, 2015. For the quarter, the company's revenues exceeded CAD 8 million, an increase of 42% from the previous quarter. Net income was CAD 132,000 against net loss of CAD 693,000 a year ago. Adjusted EBITDA was CAD 1,161,000 against adjusted EBITDA loss of CAD 441,000 a year ago. Adjusted EBITDA before new facility start-up costs was CAD 1,256,000 against adjusted EBITDA loss before new facility start-up costs of CAD 441,000 a year ago. Adjusted EBITDA before sales and marketing was CAD 2,754,000 against adjusted EBITDA loss before sales and marketing of CAD 199,000 a year ago.

For the full year, the company reported net loss of CAD 499,000 against CAD 1,882,000 a year ago. Adjusted EBITDA was CAD 2,454,000 against adjusted EBITDA loss of CAD 817,000 a year ago. Adjusted EBITDA before new facility start-up costs was CAD 3,026,000 against adjusted EBITDA loss before new facility start-up costs of CAD 817,000 a year ago. Adjusted EBITDA before sales and marketing was CAD 6,184,000 against adjusted EBITDA loss before sales and marketing of CAD 274,000 a year ago.